Candace Cameron Bure Provides Update on Dave Coulier's Health During His Cancer Battle
February 9, 2025 - 00:26
In a heartfelt conversation at the 32nd Annual Movieguide Awards, Candace Cameron Bure shared insights about her longtime friend and 'Full House' co-star, Dave Coulier. She revealed that she frequently reaches out to Coulier, who is currently undergoing treatment for stage 3 non-Hodgkin lymphoma, a diagnosis he received in October 2024.
Bure expressed her admiration for Coulier's resilience during this challenging time, emphasizing that he remains optimistic and strong as he navigates his recovery journey. The support from friends and family has been crucial for Coulier, and Bure's regular check-ins serve as a reminder of their enduring bond.
As fans continue to rally behind him, Bure's updates bring a sense of hope and solidarity. The entertainment community stands united in sending positive thoughts and prayers for Coulier's health and well-being as he fights this battle with courage and determination.
MORE NEWS
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...